APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valbenazine API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valbenazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025197 pages

Choose your research edition.

Industry ResearchValbenazine API Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Valbenazine API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Valbenazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valbenazine API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Valbenazine API Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Valbenazine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valbenazine API include Zhejiang Hengtengfu Pharmaceutical, Shaanxi Dideu Medichem, Nantong HI-FUTURE Biology, Jiangxi LongLife Bio-pharmaceutical, Jiangsu Vcare PharmaTech, Chengdu Miracle Pharmaceutical, SynZeal Research, MSN Laboratories and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valbenazine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valbenazine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valbenazine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valbenazine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Valbenazine API Segment by Company

Zhejiang Hengtengfu Pharmaceutical

Shaanxi Dideu Medichem

Nantong HI-FUTURE Biology

Jiangxi LongLife Bio-pharmaceutical

Jiangsu Vcare PharmaTech

Chengdu Miracle Pharmaceutical

SynZeal Research

MSN Laboratories

Lupin

Acharya Chemical

Valbenazine API Segment by Type

Purity ≥ 98%

Purity ≥ 99%

Valbenazine API Segment by Application

Online Sales

Offline Sales

Valbenazine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valbenazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valbenazine API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valbenazine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valbenazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valbenazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valbenazine API Industry Trends Table 2. Valbenazine API Industry Drivers Table 3. Valbenazine API Industry Opportunities and Challenges Table 4. Valbenazine API Industry Restraints Table 5. Global Valbenazine API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valbenazine API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valbenazine API Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Valbenazine API Sales Market Share by Manufacturers Table 9. Global Valbenazine API Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Valbenazine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valbenazine API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valbenazine API Manufacturers, Product Type & Application Table 13. Global Valbenazine API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valbenazine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity ≥ 98% Table 17. Major Manufacturers of Purity ≥ 99% Table 18. Global Valbenazine API Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Valbenazine API Sales by Type (2021-2026) & (Tons) Table 20. Global Valbenazine API Sales by Type (2027-2032) & (Tons) Table 21. Global Valbenazine API Sales Market Share by Type (2021-2026) Table 22. Global Valbenazine API Sales Market Share by Type (2027-2032) Table 23. Global Valbenazine API Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Valbenazine API Revenue by Type (2021-2026) & (Tons) Table 25. Global Valbenazine API Revenue by Type (2027-2032) & (Tons) Table 26. Global Valbenazine API Revenue Market Share by Type (2021-2026) Table 27. Global Valbenazine API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Sales Table 29. Major Manufacturers of Offline Sales Table 30. Global Valbenazine API Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Valbenazine API Sales by Application (2021-2026) & (Tons) Table 32. Global Valbenazine API Sales by Application (2027-2032) & (Tons) Table 33. Global Valbenazine API Sales Market Share by Application (2021-2026) Table 34. Global Valbenazine API Sales Market Share by Application (2027-2032) Table 35. Global Valbenazine API Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Valbenazine API Revenue by Application (2021-2026) & (Tons) Table 37. Global Valbenazine API Revenue by Application (2027-2032) & (Tons) Table 38. Global Valbenazine API Revenue Market Share by Application (2021-2026) Table 39. Global Valbenazine API Revenue Market Share by Application (2027-2032) Table 40. Global Valbenazine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 41. Global Valbenazine API Sales by Region (2021-2026) & (Tons) Table 42. Global Valbenazine API Sales Market Share by Region (2021-2026) Table 43. Global Valbenazine API Sales Forecasted by Region (2027-2032) & (Tons) Table 44. Global Valbenazine API Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 46. North America Valbenazine API Sales by Country (2021-2026) & (Tons) Table 47. North America Valbenazine API Sales by Country (2027-2032) & (Tons) Table 48. Europe Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. Europe Valbenazine API Sales by Country (2021-2026) & (Tons) Table 50. Europe Valbenazine API Sales by Country (2027-2032) & (Tons) Table 51. Asia Pacific Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Asia Pacific Valbenazine API Sales by Country (2021-2026) & (Tons) Table 53. Asia Pacific Valbenazine API Sales by Country (2027-2032) & (Tons) Table 54. South America, Middle East and Africa Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. South America, Middle East and Africa Valbenazine API Sales by Country (2021-2026) & (Tons) Table 56. South America, Middle East and Africa Valbenazine API Sales by Country (2027-2032) & (Tons) Table 57. Global Valbenazine API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valbenazine API Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Valbenazine API Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Valbenazine API Revenue Market Share by Region (2021-2026) Table 61. Global Valbenazine API Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Hengtengfu Pharmaceutical Company Information Table 63. Zhejiang Hengtengfu Pharmaceutical Business Overview Table 64. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio Table 66. Zhejiang Hengtengfu Pharmaceutical Recent Development Table 67. Shaanxi Dideu Medichem Company Information Table 68. Shaanxi Dideu Medichem Business Overview Table 69. Shaanxi Dideu Medichem Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Shaanxi Dideu Medichem Valbenazine API Product Portfolio Table 71. Shaanxi Dideu Medichem Recent Development Table 72. Nantong HI-FUTURE Biology Company Information Table 73. Nantong HI-FUTURE Biology Business Overview Table 74. Nantong HI-FUTURE Biology Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Nantong HI-FUTURE Biology Valbenazine API Product Portfolio Table 76. Nantong HI-FUTURE Biology Recent Development Table 77. Jiangxi LongLife Bio-pharmaceutical Company Information Table 78. Jiangxi LongLife Bio-pharmaceutical Business Overview Table 79. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio Table 81. Jiangxi LongLife Bio-pharmaceutical Recent Development Table 82. Jiangsu Vcare PharmaTech Company Information Table 83. Jiangsu Vcare PharmaTech Business Overview Table 84. Jiangsu Vcare PharmaTech Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio Table 86. Jiangsu Vcare PharmaTech Recent Development Table 87. Chengdu Miracle Pharmaceutical Company Information Table 88. Chengdu Miracle Pharmaceutical Business Overview Table 89. Chengdu Miracle Pharmaceutical Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio Table 91. Chengdu Miracle Pharmaceutical Recent Development Table 92. SynZeal Research Company Information Table 93. SynZeal Research Business Overview Table 94. SynZeal Research Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. SynZeal Research Valbenazine API Product Portfolio Table 96. SynZeal Research Recent Development Table 97. MSN Laboratories Company Information Table 98. MSN Laboratories Business Overview Table 99. MSN Laboratories Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. MSN Laboratories Valbenazine API Product Portfolio Table 101. MSN Laboratories Recent Development Table 102. Lupin Company Information Table 103. Lupin Business Overview Table 104. Lupin Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Lupin Valbenazine API Product Portfolio Table 106. Lupin Recent Development Table 107. Acharya Chemical Company Information Table 108. Acharya Chemical Business Overview Table 109. Acharya Chemical Valbenazine API Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Acharya Chemical Valbenazine API Product Portfolio Table 111. Acharya Chemical Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Valbenazine API Distributors List Table 115. Valbenazine API Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Valbenazine API Product Image Figure 2. Global Valbenazine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valbenazine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Valbenazine API Sales (2021-2032) & (Tons) Figure 5. Global Valbenazine API Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Valbenazine API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity ≥ 98% Image Figure 9. Purity ≥ 99% Image Figure 10. Global Valbenazine API Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Valbenazine API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Valbenazine API Sales Market Share by Type (2021-2032) Figure 13. Global Valbenazine API Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Valbenazine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Valbenazine API Revenue Market Share by Type (2021-2032) Figure 16. Online Sales Image Figure 17. Offline Sales Image Figure 18. Global Valbenazine API Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Valbenazine API Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Valbenazine API Sales Market Share by Application (2021-2032) Figure 21. Global Valbenazine API Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Valbenazine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valbenazine API Revenue Market Share by Application (2021-2032) Figure 24. North America Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 25. North America Valbenazine API Sales Market Share by Country (2021-2032) Figure 26. U.S. Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 27. Canada Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Mexico Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Europe Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Valbenazine API Sales Market Share by Country (2021-2032) Figure 31. Germany Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 32. France Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 33. U.K. Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Italy Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Netherlands Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Asia Pacific Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Valbenazine API Sales Market Share by Country (2021-2032) Figure 38. China Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Japan Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 40. South Korea Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Southeast Asia Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 42. India Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Australia Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South America, Middle East and Africa Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Valbenazine API Sales Market Share by Country (2021-2032) Figure 46. Brazil Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Africa Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Saudi Arabia Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Turkey Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Argentina Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 51. UAE Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Egypt Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Chile Valbenazine API Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Global Valbenazine API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Valbenazine API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Valbenazine API Revenue (2021-2032) & (US$ Million) Figure 57. North America Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Valbenazine API Revenue (2021-2032) & (US$ Million) Figure 59. Europe Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Valbenazine API Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Valbenazine API Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Valbenazine API Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Valbenazine API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 98%
  • Purity ≥ 99%
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Zhejiang Hengtengfu Pharmaceutical
  • Shaanxi Dideu Medichem
  • Nantong HI-FUTURE Biology
  • Jiangxi LongLife Bio-pharmaceutical
  • Jiangsu Vcare PharmaTech
  • Chengdu Miracle Pharmaceutical
  • SynZeal Research
  • MSN Laboratories
  • Lupin
  • Acharya Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valbenazine API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valbenazine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valbenazine API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valbenazine API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valbenazine API Market Dynamics
  1. 2.1 Valbenazine API Industry Trends
  2. 2.2 Valbenazine API Industry Drivers
  3. 2.3 Valbenazine API Industry Opportunities and Challenges
  4. 2.4 Valbenazine API Industry Restraints
3 Valbenazine API Market by Manufacturers
  1. 3.1 Global Valbenazine API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valbenazine API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valbenazine API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valbenazine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valbenazine API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valbenazine API Manufacturers, Product Type & Application
  7. 3.7 Global Valbenazine API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valbenazine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valbenazine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valbenazine API Tier 1, Tier 2, and Tier 3
4 Valbenazine API Market by Type
  1. 4.1 Valbenazine API Type Introduction
  2. 4.1.1 Purity ≥ 98%
  3. 4.1.2 Purity ≥ 99%
  4. 4.2 Global Valbenazine API Sales by Type
  5. 4.2.1 Global Valbenazine API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Valbenazine API Sales by Type (2021-2032)
  7. 4.2.3 Global Valbenazine API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Valbenazine API Revenue by Type
  9. 4.3.1 Global Valbenazine API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Valbenazine API Revenue by Type (2021-2032)
  11. 4.3.3 Global Valbenazine API Revenue Market Share by Type (2021-2032)
5 Valbenazine API Market by Application
  1. 5.1 Valbenazine API Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Valbenazine API Sales by Application
  5. 5.2.1 Global Valbenazine API Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valbenazine API Sales by Application (2021-2032)
  7. 5.2.3 Global Valbenazine API Sales Market Share by Application (2021-2032)
  8. 5.3 Global Valbenazine API Revenue by Application
  9. 5.3.1 Global Valbenazine API Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valbenazine API Revenue by Application (2021-2032)
  11. 5.3.3 Global Valbenazine API Revenue Market Share by Application (2021-2032)
6 Global Valbenazine API Sales by Region
  1. 6.1 Global Valbenazine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valbenazine API Sales by Region (2021-2032)
  3. 6.2.1 Global Valbenazine API Sales by Region (2021-2026)
  4. 6.2.2 Global Valbenazine API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valbenazine API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valbenazine API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valbenazine API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valbenazine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valbenazine API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valbenazine API Revenue by Region
  1. 7.1 Global Valbenazine API Revenue by Region
  2. 7.1.1 Global Valbenazine API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valbenazine API Revenue by Region (2021-2026)
  4. 7.1.3 Global Valbenazine API Revenue by Region (2027-2032)
  5. 7.1.4 Global Valbenazine API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valbenazine API Revenue (2021-2032)
  8. 7.2.2 North America Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valbenazine API Revenue (2021-2032)
  11. 7.3.2 Europe Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valbenazine API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valbenazine API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valbenazine API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Hengtengfu Pharmaceutical
  2. 8.1.1 Zhejiang Hengtengfu Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Hengtengfu Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio
  6. 8.1.5 Zhejiang Hengtengfu Pharmaceutical Recent Developments
  7. 8.2 Shaanxi Dideu Medichem
  8. 8.2.1 Shaanxi Dideu Medichem Company Information
  9. 8.2.2 Shaanxi Dideu Medichem Business Overview
  10. 8.2.3 Shaanxi Dideu Medichem Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shaanxi Dideu Medichem Valbenazine API Product Portfolio
  12. 8.2.5 Shaanxi Dideu Medichem Recent Developments
  13. 8.3 Nantong HI-FUTURE Biology
  14. 8.3.1 Nantong HI-FUTURE Biology Company Information
  15. 8.3.2 Nantong HI-FUTURE Biology Business Overview
  16. 8.3.3 Nantong HI-FUTURE Biology Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nantong HI-FUTURE Biology Valbenazine API Product Portfolio
  18. 8.3.5 Nantong HI-FUTURE Biology Recent Developments
  19. 8.4 Jiangxi LongLife Bio-pharmaceutical
  20. 8.4.1 Jiangxi LongLife Bio-pharmaceutical Company Information
  21. 8.4.2 Jiangxi LongLife Bio-pharmaceutical Business Overview
  22. 8.4.3 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio
  24. 8.4.5 Jiangxi LongLife Bio-pharmaceutical Recent Developments
  25. 8.5 Jiangsu Vcare PharmaTech
  26. 8.5.1 Jiangsu Vcare PharmaTech Company Information
  27. 8.5.2 Jiangsu Vcare PharmaTech Business Overview
  28. 8.5.3 Jiangsu Vcare PharmaTech Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio
  30. 8.5.5 Jiangsu Vcare PharmaTech Recent Developments
  31. 8.6 Chengdu Miracle Pharmaceutical
  32. 8.6.1 Chengdu Miracle Pharmaceutical Company Information
  33. 8.6.2 Chengdu Miracle Pharmaceutical Business Overview
  34. 8.6.3 Chengdu Miracle Pharmaceutical Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio
  36. 8.6.5 Chengdu Miracle Pharmaceutical Recent Developments
  37. 8.7 SynZeal Research
  38. 8.7.1 SynZeal Research Company Information
  39. 8.7.2 SynZeal Research Business Overview
  40. 8.7.3 SynZeal Research Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SynZeal Research Valbenazine API Product Portfolio
  42. 8.7.5 SynZeal Research Recent Developments
  43. 8.8 MSN Laboratories
  44. 8.8.1 MSN Laboratories Company Information
  45. 8.8.2 MSN Laboratories Business Overview
  46. 8.8.3 MSN Laboratories Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MSN Laboratories Valbenazine API Product Portfolio
  48. 8.8.5 MSN Laboratories Recent Developments
  49. 8.9 Lupin
  50. 8.9.1 Lupin Company Information
  51. 8.9.2 Lupin Business Overview
  52. 8.9.3 Lupin Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Valbenazine API Product Portfolio
  54. 8.9.5 Lupin Recent Developments
  55. 8.10 Acharya Chemical
  56. 8.10.1 Acharya Chemical Company Information
  57. 8.10.2 Acharya Chemical Business Overview
  58. 8.10.3 Acharya Chemical Valbenazine API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Acharya Chemical Valbenazine API Product Portfolio
  60. 8.10.5 Acharya Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valbenazine API Value Chain Analysis
  2. 9.1.1 Valbenazine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valbenazine API Production Mode & Process
  6. 9.2 Valbenazine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valbenazine API Distributors
  9. 9.2.3 Valbenazine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst